课题基金 / 基金详情

Autonomous Microscale Manufacture of Oral Solid Dosage Forms

Autonomous Microscale Manufacture of Oral Solid Dosage Forms
口服固体剂型的自主微量生产
批准号:
2745755
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该项目将成为Made Smarter Innovation - Digital Medicines Manufacturing Research Centre(DM 2)的一部分,重点是创建一个独特的自主微型药品生产和测试系统,以选择配方和工艺,从而获得具有所需关键质量属性(CQA)的稳定产品。该平台将为解决复杂的、多长度和多维的材料-工艺-产品-性能关系进行基础研究。集成工业数字技术(IDT)将降低风险并加速药品生产,大大减少开发时间和原材料/溶剂,同时通过自我优化配方和工艺条件实现CQA目标。这将与支持行业合作伙伴共同开发,重点是1)片剂(通过直接压片)和2)胶囊(通过粉末填充)。
英文摘要
This project will be part of the Made Smarter Innovation - Digital Medicines Manufacturing Research Centre (DM2) with a focus on creating a unique autonomous microscale drug product manufacturing and testing system to select formulation and process that result in a stable product with desired critical quality attributes (CQAs). The platform will perform fundamental research into resolving the complex, multi-length and -dimensional material-process-product-performance relationship. Integrating industrial digital technologies (IDTs) will de-risk and accelerate drug product manufacture, dramatically reducing development time and raw material/solvents, whilst achieving CQA objectives by self-optimised formulation and process conditions. This will be co-developed with supporting industry partners focussing on 1) tablets (via direct compression) and 2) capsule (via powder fill).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金